Clinical Trial Update: Increased Cefazolin During Cesarean Delivery in Obese Population [Phase 4]

View source ↗

Summary

Phase 4 trial update on increased cefazolin dosing during cesarean delivery in obese and morbidly obese patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infection Cesarean Section
• Obesity
• Obesity Morbid
• Pregnancy

Drugs mentioned

• CEFAZOLIN (cefazolin sodium)

Snippet

Sponsor: MemorialCare Health System | Conditions: Obesity, Obesity, Morbid | Phase 4 | Status: COMPLETED | Results posted: 2021-02-02